LCM
CDAK

Laurion Capital Management’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Laurion Capital Management’s Portfolio CDAK Stock Details CDAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,013,300
Closed -$351K – 495
2023
Q1 		$351K Hold
2,013,300
– – ﹤0.01% 183
2022
Q4 		$800K Hold
2,013,300
– – ﹤0.01% 142
2022
Q3 		$1.57M Buy
2,013,300
+1,700,000
+543% +$1.33M 0.01% 141
2022
Q2 		$902K Buy
+313,300
New +$902K 0.01% 175